Next-generation drug repurposing using human genetics and network biology.

Area of Science:

• Pharmacology
• Genetics
• Network Biology
• Drug Discovery

Background:

• Drug discovery rates are insufficient, with high costs for novel biological therapeutics.
• Biological treatments like gene therapy are expensive, limiting accessibility for rare diseases.
• Existing drugs offer a potential solution for faster, more affordable therapeutic development.

Purpose of the Study:

• To review advancements in drug repurposing by integrating human genetics and network biology.
• To explore the potential of this approach for both rare and common diseases.
• To highlight the synergy between genetics, network biology, and machine learning for personalized medicine.

Main Methods:

• Utilizing human genetics data, particularly genome-wide association studies (GWAS).
• Applying network biology approaches to identify drug-target interactions.
• Combining these with machine learning for personalized therapeutic strategies.

Main Results:

• Drug repurposing, driven by genetics and network biology, shows promise for accelerating drug discovery.
• This integrated approach can identify existing drugs for monogenic and polygenic diseases.
• The combination with machine learning supports personalized medicine initiatives.

Conclusions:

• Integrating human genetics and network biology is a powerful next-generation strategy for drug repurposing.
• This approach offers a faster and more cost-effective path to new treatments.
• It holds significant potential for advancing personalized medicine and addressing unmet medical needs.